Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”

키워드

참고문헌 (17)

1. Ward JW, "What is needed to eliminate hepatitis B virus and hepatitis C virus as global health threats", Gastroenterology, 156, pp.297~310 (2019)
2. Thomas DL, "Global elimination of chronic hepatitis", N Engl J Med, 380, pp.2041~2050 (2019)
3. Terrault NA, "International liver transplantation society consensus statement on hepatitis C management in liver transplant candidates", Transplantation, 101, pp.945~955 (2017)
4. Ioannou GN, "Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C", J Hepatol, 69, pp.1088~1098 (2018)
5. Dyal HK, "Diabetes mellitus increases risk of hepatocellular carcinoma in chronic hepatitis C virus patients : A systematic review", Dig Dis Sci, 61, pp.636~645 (2016)
6. Gill K, "Hepatitis C virus as a systemic disease : reaching beyond the liver", Hepatol Int, 10, pp.415~423 (2016)
7. Simon TG, "Association between aspirin use and risk of hepatocellular carcinoma", JAMA Oncol, 4, pp.1683~1690 (2018)
8. Kim G, "Statin use and the risk of hepatocellular carcinoma in patients at high risk : A nationwide nested case-control study", J Hepatol, 68, pp.476~484 (2018)
9. Tsai PC, "Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan", J Hepatol, 78, pp.281~292 (2023)
10. Wang L, "Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes", Gastroenterology, 167, pp.689~703 (2024)
11. Tsai PC, "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy", Clin Mol Hepatol, 30, pp.468~486 (2024)
12. Simon TG, "Lipophilic statins and risk for hepatocellular carcinoma and death in patients with chronic viral hepatitis : Results from a Nationwide Swedish population", Ann Intern Med, 171, pp.318~327 (2019)
13. Li H, "Hepatitis C : From inflammatory pathogenesis to anti-inflammatory", hepatoprotective therapy, 2018, pp.24, 5297~5311
14. Athuluri-Divakar SK, "Generic chemoprevention of hepatocellular carcinoma", Ann N Y Acad Sci, 1440, pp.23~35 (2019)
15. Goh MJ, "Statin and aspirin for chemoprevention of hepatocellular carcinoma : Time to use or wait further?", Clin Mol Hepatol, 28, pp.380~395 (2022)
16. Arvanitakis K, "Management of type 2 diabetes in patients with compensated liver cirrhosis : Short of evidence, plenty of potential", Diabetes Metab Syndr, 18, pp.102935~ (2024)
17. Wong YJ, "Efficacy and safety of statin for hepatocellular carcinoma prevention among chronic liver disease patients : A systematic review and metaanalysis", J Clin Gastroenterol, 55, pp.615~623 (2021)

관련 논문AI추천